DIALYTE 3.5 G
SODIUM CHLORIDE : 3.5 G SODIUM BICARBONATE : 2.5 G POTASSIUM CHLORIDE : 1.5 G DEXTROSE : 20 G · DIN 00574880 · IAMAT (INTER ASSOC MEDIC ASSIST TRAVEL)
Health Canada status: CANCELLED POST MARKET
What is DIALYTE?
DIALYTE 3.5 G contains SODIUM CHLORIDE : 3.5 G SODIUM BICARBONATE : 2.5 G POTASSIUM CHLORIDE : 1.5 G DEXTROSE : 20 G. It is listed in the Health Canada Drug Product Database under DIN 00574880, held by IAMAT (INTER ASSOC MEDIC ASSIST TRAVEL), supplied as POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 07-Jul-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00574880 |
|---|---|
| Brand name | DIALYTE |
| Generic / active ingredient | SODIUM CHLORIDE : 3.5 G SODIUM BICARBONATE : 2.5 G POTASSIUM CHLORIDE : 1.5 G DEXTROSE : 20 G |
| Manufacturer | IAMAT (INTER ASSOC MEDIC ASSIST TRAVEL) |
| Strength | 3.5 G |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07CA ORAL REHYDRATION SALT FORMULATIONS |
| AHFS class | 34:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 07-Jul-1997 |
| Original market date | 1982-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A07CA ORAL REHYDRATION SALT FORMULATIONS. 0 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| GASTROLYTE | 470 MG | POWDER FOR SOLUTION | AVENTIS PHARMA INC | CANCELLED POST MARKET | DIN 01931555 |
| LYTREN | 2 G / 100 ML | LIQUID | MEAD JOHNSON NUTRITIONALS | CANCELLED POST MARKET | DIN 00654957 |
| LYTREN RHS LIQ | 375 MG / 100 ML | LIQUID | MEAD JOHNSON NUTRITIONALS | CANCELLED POST MARKET | DIN 00841803 |
| REHYDRALYTE | 25 MG | LIQUID | ROSS LABORATORIES, DIVISION OF ABBOTT LABORATORIES LTD. | CANCELLED POST MARKET | DIN 00763195 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.